BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12752183)

  • 1. Clinical study of primary cutaneous B-cell lymphoma using both the European Organization for Research and Treatment of Cancer and World Health Organization classifications.
    Yap LM; Blum R; Foley P; McCormack C; Turner H; Seymour JF; Prince HM
    Australas J Dermatol; 2003 May; 44(2):110-5. PubMed ID: 12752183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers.
    Senff NJ; Hoefnagel JJ; Jansen PM; Vermeer MH; van Baarlen J; Blokx WA; Canninga-van Dijk MR; Geerts ML; Hebeda KM; Kluin PM; Lam KH; Meijer CJ; Willemze R
    J Clin Oncol; 2007 Apr; 25(12):1581-7. PubMed ID: 17353548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and treatment outcomes of primary cutaneous B-cell lymphoma: a single-center analysis in South Korea.
    Kim MJ; Hong ME; Maeng CH; Jung HA; Hong JY; Choi MK; Kim SJ; Ko YH; Kim WS
    Int J Hematol; 2015 Mar; 101(3):273-8. PubMed ID: 25552248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary cutaneous B-cell lymphoma treated with radiotherapy: a comparison of the European Organization for Research and Treatment of Cancer and the WHO classification systems.
    Smith BD; Glusac EJ; McNiff JM; Smith GL; Heald PW; Cooper DL; Wilson LD
    J Clin Oncol; 2004 Feb; 22(4):634-9. PubMed ID: 14966086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment and outcomes in patients with primary cutaneous B-cell lymphoma: the BC Cancer Agency experience.
    Hamilton SN; Wai ES; Tan K; Alexander C; Gascoyne RD; Connors JM
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):719-25. PubMed ID: 24001373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary cutaneous B-cell lymphoma in Nottinghamshire U.K.: prognosis of subtypes defined in the WHO-EORTC classification.
    Bessell EM; Humber CE; O'Connor S; English JS; Perkins W; Dickinson PD; Patel AN
    Br J Dermatol; 2012 Nov; 167(5):1118-23. PubMed ID: 22759204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of radiotherapy in 153 primary cutaneous B-Cell lymphomas classified according to the WHO-EORTC classification.
    Senff NJ; Hoefnagel JJ; Neelis KJ; Vermeer MH; Noordijk EM; Willemze R;
    Arch Dermatol; 2007 Dec; 143(12):1520-6. PubMed ID: 18087001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary Cutaneous B-Cell Lymphoma: Management and Patterns of Recurrence at the Multimodality Cutaneous Lymphoma Clinic of The Ohio State University.
    Haverkos B; Tyler K; Gru AA; Winardi FK; Frederickson J; Hastings J; Elkins C; Zhang X; Xu-Welliver M; Wong HK; Porcu P
    Oncologist; 2015 Oct; 20(10):1161-6. PubMed ID: 26306900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study.
    Grange F; Bekkenk MW; Wechsler J; Meijer CJ; Cerroni L; Bernengo M; Bosq J; Hedelin G; Fink Puches R; van Vloten WA; Joly P; Bagot M; Willemze R
    J Clin Oncol; 2001 Aug; 19(16):3602-10. PubMed ID: 11504742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary cutaneous B-cell lymphomas - clinicopathological, prognostic and therapeutic characterisation of 54 cases according to the WHO-EORTC classification and the ISCL/EORTC TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome.
    Golling P; Cozzio A; Dummer R; French L; Kempf W
    Leuk Lymphoma; 2008 Jun; 49(6):1094-103. PubMed ID: 18569636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term efficacy, curative potential, and prognostic factors of radiotherapy in primary cutaneous B-cell lymphoma.
    Eich HT; Eich D; Micke O; Süttzer H; Casper C; Krieg T; Müller RP
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):899-906. PubMed ID: 12605967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary cutaneous large B-cell lymphomas: relevance of the 2017 World Health Organization classification: clinicopathological and molecular analyses of 64 cases.
    Menguy S; Beylot-Barry M; Parrens M; Ledard AP; Frison E; Comoz F; Battistella M; Szablewski V; Balme B; Croue A; Franck F; Ortonne N; Tournier E; Lamant L; Carlotti A; De Muret A; Le Gall F; Lorton MH; Merlio JP; Vergier B
    Histopathology; 2019 Jun; 74(7):1067-1080. PubMed ID: 30715765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas.
    Zinzani PL; Quaglino P; Pimpinelli N; Berti E; Baliva G; Rupoli S; Martelli M; Alaibac M; Borroni G; Chimenti S; Alterini R; Alinari L; Fierro MT; Cappello N; Pileri A; Soligo D; Paulli M; Pileri S; Santucci M; Bernengo MG;
    J Clin Oncol; 2006 Mar; 24(9):1376-82. PubMed ID: 16492713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of primary cutaneous B-cell lymphomas].
    Zenahlik P; Fink-Puches R; Kapp KS; Kerl H; Cerroni L
    Hautarzt; 2000 Jan; 51(1):19-24. PubMed ID: 10663035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The histomorphologic spectrum of primary cutaneous diffuse large B-cell lymphoma: a study of 79 cases.
    Plaza JA; Kacerovska D; Stockman DL; Buonaccorsi JN; Baillargeon P; Suster S; Kazakov DV
    Am J Dermatopathol; 2011 Oct; 33(7):649-55; quiz 656-8. PubMed ID: 21937906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary cutaneous large B-cell lymphoma of the leg: histogenetic analysis of a controversial clinicopathologic entity.
    Paulli M; Viglio A; Vivenza D; Capello D; Rossi D; Riboni R; Lucioni M; Incardona P; Boveri E; Bellosta M; Orlandi E; Borroni G; Lazzarino M; Berti E; Alessi E; Magrini U; Gaidano G
    Hum Pathol; 2002 Sep; 33(9):937-43. PubMed ID: 12378521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of multifocal primary cutaneous B-cell lymphoma: a clinical follow-up study of 29 patients.
    Bekkenk MW; Vermeer MH; Geerts ML; Noordijk EM; Heule F; van Voorst Vader PC; van Vloten WA; Meijer CJ; Willemze R
    J Clin Oncol; 1999 Aug; 17(8):2471-8. PubMed ID: 10561311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary cutaneous marginal zone B-cell lymphoma: response to treatment and disease-free survival in a series of 137 patients.
    Servitje O; Muniesa C; Benavente Y; Monsálvez V; Garcia-Muret MP; Gallardo F; Domingo-Domenech E; Lucas A; Climent F; Rodriguez-Peralto JL; Ortiz-Romero PL; Sandoval J; Pujol RM; Estrach MT
    J Am Acad Dermatol; 2013 Sep; 69(3):357-65. PubMed ID: 23796549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling.
    Hoefnagel JJ; Dijkman R; Basso K; Jansen PM; Hallermann C; Willemze R; Tensen CP; Vermeer MH
    Blood; 2005 May; 105(9):3671-8. PubMed ID: 15308563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
    Grange F; Beylot-Barry M; Courville P; Maubec E; Bagot M; Vergier B; Souteyrand P; Machet L; Dalac S; Esteve E; Templier I; Delaporte E; Avril MF; Robert C; Dalle S; Laroche L; Delaunay M; Joly P; Wechsler J; Petrella T
    Arch Dermatol; 2007 Sep; 143(9):1144-50. PubMed ID: 17875875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.